These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
432 related articles for article (PubMed ID: 30962764)
1. Prognostic significance of elevated pretreatment systemic inflammatory markers for patients with prostate cancer: a meta-analysis. Peng H; Luo X Cancer Cell Int; 2019; 19():70. PubMed ID: 30962764 [TBL] [Abstract][Full Text] [Related]
2. Prognostic value of inflammatory markers NLR, PLR, and LMR in gastric cancer patients treated with immune checkpoint inhibitors: a meta-analysis and systematic review. Tan S; Zheng Q; Zhang W; Zhou M; Xia C; Feng W Front Immunol; 2024; 15():1408700. PubMed ID: 39050856 [TBL] [Abstract][Full Text] [Related]
3. Prognostic Significance of Pretreatment Neutrophil-to-Lymphocyte Ratio, Platelet-to-Lymphocyte Ratio, or Monocyte-to-Lymphocyte Ratio in Endometrial Neoplasms: A Systematic Review and Meta-analysis. Leng J; Wu F; Zhang L Front Oncol; 2022; 12():734948. PubMed ID: 35651788 [TBL] [Abstract][Full Text] [Related]
4. Predictive Value of Pretreatment Lymphocyte-to-Monocyte Ratio and Platelet-to-Lymphocyte Ratio in the Survival of Nasopharyngeal Carcinoma Patients. Chen Y; Sun J; Hu D; Zhang J; Xu Y; Feng H; Chen Z; Luo Y; Lou Y; Wu H Cancer Manag Res; 2021; 13():8767-8779. PubMed ID: 34866938 [TBL] [Abstract][Full Text] [Related]
5. The clinical use of the platelet/lymphocyte ratio and lymphocyte/monocyte ratio as prognostic predictors in colorectal cancer: a meta-analysis. Guo YH; Sun HF; Zhang YB; Liao ZJ; Zhao L; Cui J; Wu T; Lu JR; Nan KJ; Wang SH Oncotarget; 2017 Mar; 8(12):20011-20024. PubMed ID: 28212553 [TBL] [Abstract][Full Text] [Related]
6. Pretreatment hematologic markers as prognostic factors in patients with nasopharyngeal carcinoma: A systematic review and meta-analysis. Su L; Zhang M; Zhang W; Cai C; Hong J Medicine (Baltimore); 2017 Mar; 96(11):e6364. PubMed ID: 28296774 [TBL] [Abstract][Full Text] [Related]
7. Prognostic value of preoperative lymphocyte-related systemic inflammatory biomarkers in upper tract urothelial carcinoma patients treated with radical nephroureterectomy: a systematic review and meta-analysis. Shao Y; Li W; Wang D; Wu B World J Surg Oncol; 2020 Oct; 18(1):273. PubMed ID: 33097052 [TBL] [Abstract][Full Text] [Related]
8. Prognostic role of neutrophil to lymphocyte ratio and platelet to lymphocyte ratio in prostate cancer: A meta-analysis of results from multivariate analysis. Guo J; Fang J; Huang X; Liu Y; Yuan Y; Zhang X; Zou C; Xiao K; Wang J Int J Surg; 2018 Dec; 60():216-223. PubMed ID: 30468905 [TBL] [Abstract][Full Text] [Related]
9. Neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio as biomarkers to prognosticate survival in advanced gastric cancer patients in the era of immunotherapy: a systematic review and meta-analysis. Matsas S; Aguiar PN; Del Giglio A J Gastrointest Oncol; 2024 Feb; 15(1):33-51. PubMed ID: 38482212 [TBL] [Abstract][Full Text] [Related]
10. Pretreatment Inflammatory Indexes as Prognostic Predictors of Survival in Patients Suffering From Synovial Sarcoma. Cheng Y; Mo F; Pu L; Li Q; Ma X Front Oncol; 2019; 9():955. PubMed ID: 31608240 [No Abstract] [Full Text] [Related]
11. Revealing the prognostic landscape of neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in metastatic castration-resistant prostate cancer patients treated with abiraterone or enzalutamide: a meta-analysis. Guan Y; Xiong H; Feng Y; Liao G; Tong T; Pang J Prostate Cancer Prostatic Dis; 2020 Jun; 23(2):220-231. PubMed ID: 32034294 [TBL] [Abstract][Full Text] [Related]
12. Preoperative lymphocyte-to-monocyte ratio represents a superior predictor compared with neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios for colorectal liver-only metastases survival. Peng J; Li H; Ou Q; Lin J; Wu X; Lu Z; Yuan Y; Wan D; Fang Y; Pan Z Onco Targets Ther; 2017; 10():3789-3799. PubMed ID: 28794643 [TBL] [Abstract][Full Text] [Related]
13. Prognostic value of systemic inflammatory markers in ovarian Cancer: a PRISMA-compliant meta-analysis and systematic review. Zhu Y; Zhou S; Liu Y; Zhai L; Sun X BMC Cancer; 2018 Apr; 18(1):443. PubMed ID: 29669528 [TBL] [Abstract][Full Text] [Related]
14. Prognostic and predictive value of neutrophil-to-lymphocyte ratio after curative rectal cancer resection: A systematic review and meta-analysis. Hamid HKS; Davis GN; Trejo-Avila M; Igwe PO; Garcia-Marín A Surg Oncol; 2021 Jun; 37():101556. PubMed ID: 33819850 [TBL] [Abstract][Full Text] [Related]
15. Pretreatment PLR Is Preferable to NLR and LMR as a Predictor in Locally Advanced and Metastatic Bladder Cancer. Karan C; Yaren A; Demirel BC; Dogan T; Ozdemir M; Demiray AG; Taskoylu BY; Degirmencioglu S; Dogu G; Ozhan N; Cakiroglu U; Celikyurek A Cancer Diagn Progn; 2023; 3(6):706-715. PubMed ID: 37927800 [TBL] [Abstract][Full Text] [Related]
16. Prognostic role of pretreatment neutrophil-to-lymphocyte ratio in non-small cell lung cancer patients treated with systemic therapy: a meta-analysis. Wang Z; Zhan P; Lv Y; Shen K; Wei Y; Liu H; Song Y Transl Lung Cancer Res; 2019 Jun; 8(3):214-226. PubMed ID: 31367535 [TBL] [Abstract][Full Text] [Related]
17. Preoperative Neutrophil Lymphocyte Ratio Can Be Used as a Predictor of Prognosis in Patients With Adenocarcinoma of the Esophagogastric Junction: A Systematic Review and Meta Analysis. Liu XB; Gao ZY; Zhang QH; Pandey S; Gao B; Yang F; Tong Q; Li SB Front Oncol; 2020; 10():178. PubMed ID: 32154173 [No Abstract] [Full Text] [Related]
18. Prognostic value of neutrophil/lymphocyte, platelet/lymphocyte, lymphocyte/monocyte ratios and Glasgow prognostic score in osteosarcoma: A meta-analysis. Peng LP; Li J; Li XF World J Clin Cases; 2022 Mar; 10(7):2194-2205. PubMed ID: 35321179 [TBL] [Abstract][Full Text] [Related]
19. Predictive value of neutrophil-lymphocyte ratio and platelet-lymphocyte ratio in non-small cell lung cancer patients treated with immune checkpoint inhibitors: A meta-analysis. Zhang N; Jiang J; Tang S; Sun G Int Immunopharmacol; 2020 Aug; 85():106677. PubMed ID: 32531712 [TBL] [Abstract][Full Text] [Related]
20. Prognostic Study of Inflammatory Markers in Nasopharyngeal Carcinoma Patients Receiving Intensity-Modulated Radiotherapy. Tang L; Li X; Wang Y; Tong Y Cancer Manag Res; 2024; 16():1321-1328. PubMed ID: 39372707 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]